Cross-Resistance Studies of Isogenic Drug-Resistant Breast Tumor Cell Lines Support Recent Clinical Evidence Suggesting that Sensitivity to Paclitaxel may be Strongly Compromised by Prior Doxorubicin Exposure

By Guo Baoqing  

Breast Cancer Research and Treatment, Vol. 85, Iss. 1, 2004-05 ,pp. : 31-51

Springer Publishing Company

Access to resources Recommend Favorite

Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis

By Laere Steven  

Breast Cancer Research and Treatment, Vol. 93, Iss. 3, 2005-10 ,pp. : 237-246

Springer Publishing Company

Access to resources Recommend Favorite

Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis

By Cassone Marco  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 217-218

Informa Healthcare

Access to resources Recommend Favorite

Potent Killing of Paclitaxel- and Doxorubicin-resistant Breast Cancer Cells by Calphostin C Accompanied by Cytoplasmic Vacuolization

By Guo Baoqing   Hembruff Stacey L.   Villeneuve David J.   Kirwan Angie F.   Parissenti Amadeo M.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 2, 2003-11 ,pp. : 125-141

Springer Publishing Company

Access to resources Recommend Favorite

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells

By Huang Fang   Wu Xiao-Nan   Chen Jie   Wang Wen-Xiang   Lu ZuFu  

Experimental and Therapeutic Medicine, Vol. 7, Iss. 6, 2014-06 ,pp. : 1611-1616

Spandidos Publications

Access to resources Recommend Favorite